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It has been reported that gdT cells are required for
transfer of contact hypersensitivity responses by
hapten-primed T cells. The mechanism by which
they do so, however, remains to be elucidated. To
speci®cally investigate the role of gdT cells in the
development of contact hypersensitivity, this study
employed Td gene knockout mice that are de®cient
in gdT cells but are normal in the development of
abT cells. The result indicates that contact hyper-
sensitivity responses were signi®cantly greater in gdT
cell de®cient mice than in wild-type mice. Similar
results were obtained when wild-type mice were
depleted of gdT cells with antibody treatment before
hapten sensitization. Depletion of CD4+ T cells did
not affect the increased contact hypersensitivity
response in gdT cell de®cient mice, suggesting that
the effect of gdT cells is on CD8+ T cells and does
not require CD4+ T cells. Further experiments
demonstrated that primed CD8+ T cells from the
de®cient mice exhibited signi®cantly higher CTL
activity. The cytokine pro®le of CD4+ T cells was
not signi®cantly altered. Transfer of primed lymph
node cells from hapten-primed gdT cell de®cient
mice elicited a similar level of contact hypersensi-
tivity in naive wild-type and the de®cient recipient
mice, indicating that gdT cells have little effect on
the elicitation of primed T cells and contact hyper-
sensitivity responses. We conclude that gdT cells
downregulate contact hypersensitivity responses to
hapten sensitization by limiting the development of
hapten-speci®c CD8+ effector T cells during sensitiz-
ation and that this effect is independent of CD4+ T
cells. Key words: cellular activation/delayed-type hypersen-
sitivity/skin/T lymphocytes. J Invest Dermatol 119:137±
142, 2002
g dT cells are a subpopulation of T cells that are abundantin the skin and epithelia of many tissues, but are rarelyfound in lymphoid organs (Hein and Mackay, 1991).
Their relative absence in lymphoid organs is consistent
with the hypothesis that antigen recognition by gdT cells
is different from that of abT cells (De Libero, 1997). In support of
this contention, studies have shown that cutaneous gdT cells can be
activated by haptenated keratinocytes/epidermal cells (Huber et al,
1995) and that the activation of gdT cells, unlike that of abT cells,
is not restricted by major histocompatibility complex class I or II
molecules (Grusby et al, 1993; Schild et al, 1994). Despite these
differences, gdT cells, like abT cells, are able to differentiate into
Th1 and Th2 phenotypes and upon stimulation with antigen can
produce interferon-g (IFN-g) and interleukin-4 (IL-4) (Wen et al,
1994; Ferrick et al, 1995; Wen et al, 1998). Functionally, gdT cells
can provide help for B cell development and antibody production
(Maloy et al, 1998), although they more generally play a regulatory
role in the development of immune abT cells and of in¯ammatory
reactions (Fujihashi et al, 1996; Zuany-Amorim et al, 1998; Hayday,
2000).
Most studies looking at gdT cells have focused on immune
responses mediated by CD4+ T cells. Their role in CD8+ T cell
development and in CD8+-mediated immune responses has
received much less attention, although one report has shown that
gdT cells regulate the development of noncytolytic CD8+ regu-
latory cells in the tolerance induced by orally administered antigens.
In the absence of gdT cells, CD8+ T cells developed into cytotoxic
T cells and tolerance was abolished (Ke et al, 1997).
There is evidence implicating a role of gdT cells in the
development of contact hypersensitivity (CHS) (Dieli et al, 1994;
Askenase et al, 1995). High dose hapten-induced tolerance results in
the generation of gdT cells that inhibit IFN-g production and the
transfer of CHS responses by primed abT cells (Szczepanik et al,
1996), although the mechanisms by which gdT cells regulate
hapten-speci®c abT cells and CHS responses are largely un-
explored.
In CHS, a group of studies have demonstrated that CD8+ T cells
develop into effector cells whereas depletion of CD4+ T cells
increases the response (Gocinski and Tigelaar, 1990; Anderson et al,
1995; Xu et al, 1996). There is evidence, however, indicating that
CD4+ T cells can also function as effector cells (Hauser, 1992;
Wang et al, 2000). The effector cells in CHS, both CD4+ and
CD8+ T cells, produce IFN-g, which is a major factor mediating
in¯ammatory reactions in hapten-challenged tissues (Grabbe and
Schwarz, 1998). Recently, it has been demonstrated that the
cytotoxic activity of hapten-speci®c T cells plays a critical role in
the elicitation of CHS responses (Kehren et al, 1999), indicating
that the mechanism for CHS responses involves multiple factors.
We decided to examine the mechanism by which gdT cells
regulate CD8+ T-cell-mediated immune responses, because of the
paucity of information on this issue. In this study, Td gene
knockout mice and mice that were de®cient in gdT cells by in vivo
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injection of antibody were used to address the role of gdT cells in
CHS responses. Our studies indicate that gdT cells inhibit hapten-
speci®c CD8+ T cells directly, rather than through an indirect
effect on CD4+ T cells. The studies demonstrate that gdT cells
regulate CD8+ effector cells in CHS.
MATERIALS AND METHODS
Animals and reagents Td gene knockout mice on a C57BL/6
background were purchased from Jackson's Laboratories (Jackson's
Laboratories, Bar Harbor, ME). In these mice, the development of gdT
cells is de®cient due to a targeted disruption of the Td gene whereas
abT cells are not affected (Itohara et al, 1993). The de®ciency of gdT
cells in the mice was veri®ed by staining spleen, lymph node cells, and
epidermal sheets with phycoerythrin-labeled gdT-cell-speci®c antibody
GL3 (Pharmingen) (data not shown). These mice were bred in the
animal facility at the University of Alabama at Birmingham according to
the University IACUC regulations. Only female mice were used for
experiments. The age and sex matched wild-type C57BL/6 mice were
purchased from Charles River (Charles River, Wilmington, MA). The
hybridomas that produce anti-Td chain antibody (UC7±13D5),
antimouse CD4 (GK1.5), or CD8 (Lyt-2) antibodies were purchased
from ATCC (ATCC, Rockville, MD). The antibody was puri®ed from
culture supernatants by af®nity chromatography using protein-G coupled
columns (GmmaBind Plus, Pharmacia, Piscataway, NJ).
Sensitization and elicitation of CHS The induction and elicitation of
CHS responses in mice was carried out as described previously (Xu et al,
1996). Brie¯y, mice were sensitized with 25 ml of 0.5% 2,4-dinitro-
¯uorobenzene (DNFB; Sigma, St Louis, MO) on the shaved abdomen
and 5 ml on each footpad on two consecutive days. For sensitization
with oxazolone (OX; Sigma), mice were painted once with 50 ml of 3%
OX on the shaved abdomen and 5 ml on each footpad. The sensitized
mice were challenged 5 d later with 10 ml of 0.2% DNFB or 1% OX on
each side of both ears. The increase in ear thickness was read 24 h
following challenge and then at 24 h intervals. Naive mice that were not
sensitized but hapten challenged served as negative controls. The
magnitude of ear thickness is given as the mean increase in each group
of at least three mice (i.e., six ears).
In vivo depletion of T cell subsets In vivo depletion of gdT cells,
CD4+ or CD8+ T cells was performed by treatment of animals with
speci®c antibodies as previously described (Xu et al, 1996). Brie¯y, mice
were given an intraperitoneal injection of 100 mg GK1.5 (anti-CD4),
Lyt-2 (anti-CD8), or UC7-13D5 (anti-Td) on three consecutive days.
The mice were rested for 1 d and then sensitized. Control mice were
treated with normal rat IgG (Sigma) according to the same protocol. The
spleen and lymph node cells of treated mice were stained with
¯uorescence-labeled anti-CD4 (L3T4), anti-CD8 (Ly2), or gdT cell
antibody (GL3, Pharmingen, San Diego, CA) to determine the ef®ciency
of T cell subset depletion. The result was analyzed by ¯ow cytometry.
The antibody treatment resulted in over 90% depletion of the target cells
(data not shown).
Transfer of CHS responses To examine the effect of gdT cells on the
elicitation of CHS responses, gdT cell de®cient mice were sensitized
with DNFB or OX. The draining lymph node cells were taken on day 5
and transferred intravenously into naive wild-type or gdT cell de®cient
mice at 30±40 3 106 cells per mouse. Recipient mice were ear
challenged immediately thereafter with the same hapten. The ear
swelling response was read at 24 h intervals following challenge. Naive
mice without cell transfer served as negative controls.
Cell cultures In vitro stimulation of cytokine production by hapten-
primed T cells was described previously (Xu et al, 1996). Brie¯y, mice
were sensitized with 0.5% DNFB and the draining lymph node cells
were cultured on anti-CD3 antibody coated wells. Supernatants were
harvested 48 h later for measurement of cytokines by enzyme-linked
immunosorbent assay (ELISA).
To detect cytokine production stimulated by hapten-labeled dendritic
cells, bone marrow derived dendritic cells were generated as described
previously (Xu et al, 2001). Dendritic cells were labeled with 2,4-
Dinitrobemenesulfonic acid, sodium salt (DNBS) (5 mM) at 37°C for
10 min, washed vigorously, and irradiated with 2000 rad. Mice were
sensitized with DNFB and draining lymph node T cells (2 3 105 per
well) were cocultured with hapten-labeled dendritic cells (2 3 104 per
well) in 96-well culture plates. Supernatants were harvested 48 h later for
determination of cytokines by ELISA.
For determination of CTL activity, 24 ¯at-bottom-well tissue culture
plates (Costar, Cambridge, MA) were coated with 100 ml per well of
anti-CD3 antibody at 50 mg per ml at 37°C for 90 min. After three
washes with phosphate-buffered saline, 2 3 106 lymph node cells from
sensitized or naive mice were placed in 1 ml of complete medium
supplemented with recombinant mouse IL-2 (Sigma) at 10 U per ml.
After 4 d, cells were harvested as effector cells for use in CTL assays.
Cytokine ELISA The cytokine-speci®c sandwich ELISA for
determining quantities of IFN-g and IL-4 has been described previously
(Xu et al, 1996). The antibodies and recombinant cytokines for the
standard curve were purchased from Pharmingen. All samples were
tested undiluted and in at least two to three dilutions. Each sample of
culture supernatant and standard recombinant cytokine was performed in
duplicate and mean values were obtained. The concentration of each
cytokine in culture supernatants was calculated according to standard
curves.
Hapten-speci®c CTL assay EL-4 cells were hapten labeled and used
as target cells. In brief, 2±4 3 106 EL-4 cells were incubated with 1 ml
of 5 mM DNBS (Sigma) in phosphate-buffered saline at 37°C for
20 min. The cells were washed once with complete medium. One
hundred microcuries of 51Cr (sodium chromate, 1 mCi per ml,
Amersham, Piscataway, NJ) was added and incubated at 37°C for
60 min. The cells were washed three times and a sample of the cells was
counted in a gamma counter. The effector cells were mixed with the
target cells at various effector to target ratios (starting at 106 effector cells
to 104 target cells) as indicated in Results and were incubated at 37°C for
6 h. Fifty microliters of the supernatant were taken and mixed with
150 ml of SuperMix scintillation cocktail solution (Wallac, Perkin Elmer,
Wellesley, MA) in a 96-well plate. The plate was vigorously shaken for
20 min and counted in a Microbeta counter (Wallac). The
nonhaptenated EL-4 cells were used as negative controls for hapten
nonspeci®c lysis. The speci®c lysis was calculated using the formula: lysis
percentage = (cpm of sample ± cpm of spontaneous release)/(maximal
cpm ± spontaneous release). Maximal cpm was from the lysate of target
cells lyzed by 1% sodium dodecyl sulfate and spontaneous release was
from the supernatant of target cells without effector cells.
RESULTS
CHS responses are increased in Td gene knockout mice In
initial experiments to examine CHS responses in mice that are
de®cient in gdT cells, wild-type and Td gene knockout mice were
sensitized with OX and CHS responses were determined following
challenge. As described previously, CHS responses peaked at 24 h
and then declined. Mice that were not sensitized (i.e., negative
control) had only low background responses following hapten
challenge. The magnitude of CHS responses in Td gene knockout
mice was signi®cantly higher than in wild-type mice (Fig 1a, p
< 0.05). The enhancement of CHS responses in the Td gene
knockout mice suggested that gdT cells play a regulatory role in
CHS responses. Similar results were obtained when DNFB was
used as hapten (data not shown).
To exclude the possibility that other unknown de®ciencies in
the Td gene knockout mice may affect CHS responses, wild-type
C57BL/6 mice were treated in vivo with anti-Td chain antibody to
deplete gdT cells. The mice were then sensitized and CHS
responses were measured following hapten challenge. In compari-
son to nondepleted control mice that were treated with normal rat
IgG, CHS responses were signi®cantly increased in gdT cell
depleted mice (Fig 1b, p < 0.05). The magnitude was similar to
that observed in gdT cell knockout mice. These experiments
indicate that gdT cells have a regulatory role in CHS responses.
The effect of gdT cell de®ciency in the transfer of CHS
responses Previous studies indicated that gdT cells were required
for transfer of CHS responses by hapten-primed T cells, suggesting
that gdT cells play a role in elicitation of the response (Askenase et al,
1995). To examine whether the increase in the CHS response in
Td gene knockout mice was due to an effect on the induction or
the elicitation of the CHS response, hapten-primed T cells from Td
gene knockout mice were transferred into naive wild-type and Td
gene knockout recipient mice. The CHS response in the recipient
mice was measured following hapten challenge. We used primed T
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cells from gdT cell de®cient mice for the transfer experiment to
examine effects of gdT cells in recipient animals. Primed T cells
from wild-type and gdT cell de®cient mice are not comparable, as
they have different immunologic activities due to effects of gdT
cells on T cell priming. The transfer of DNFB-primed T cells of Td
gene knockout mice elicited signi®cant CHS responses in both
wild-type and Td gene knockout recipient mice (Fig 2a). The
magnitude of CHS responses in Td gene knockout recipients was
comparable to that in wild-type recipients. To further con®rm the
effect of gdT cells in elicitation of CHS responses, OX-sensitized T
cells from Td gene knockout mice were employed in transfer
experiments. Identical results were also obtained when OX was
used as hapten (Fig 2b). The data indicate that the transfer of CHS
responses does not require gdT cells and that the presence of gdT
cells in the recipient mice does not have a signi®cant effect on the
magnitude of CHS responses transferred by abT cells. This suggests
that gdT cells regulate the induction of CHS responses and play
minimal roles on the effector phase.
The increase of CHS responses in gdT cell de®cient mice is
independent of CD4+ T cells It has been shown that in CHS
depletion of CD4+ T cells enhances the response (Gocinski and
Tigelaar, 1990). The regulatory role of gdT cells in CHS could
have therefore resulted from a direct action on effector CD8+ T
cells or could have been mediated through effect on CD4+ T cells.
To examine whether the effect of gdT cells in CHS responses is
mediated through CD4+ T cells, wild-type and Td gene knockout
mice were depleted of CD4+ T cells prior to sensitization with
DNFB, and CHS responses were measured following hapten
challenge. The response in Td gene knockout mice was greater
than in wild-type mice (Fig 3), indicating that the regulatory
activity of gdT cells in CHS responses occurred independently of
CD4+ T cells.
The cytokine pro®le of hapten-sensitized T cells Following
hapten sensitization primed CD4+ T cells mainly produce Th2
cytokines IL-4 and IL-10 whereas CD8+ T cells produce IFN-g
(Xu et al, 1996). To examine whether a de®ciency in gdT cells
altered the development of hapten-speci®c T cells, the cytokine
phenotype of hapten-primed T cells in gdT cell de®cient and wild-
type mice was compared. In these experiments, the draining lymph
node cells from sensitized wild-type and Td gene knockout mice
were re-stimulated in vitro and cytokine production was measured
as described previously (Xu et al, 1996). Primed T cells from both
Figure 2. The effect of gdT cells on transfer
of CHS responses by hapten-primed T cells.
Td gene knockout mice were sensitized with
DNFB (A) or OX (B) and the draining lymph
node cells were harvested 5 d later. These cells
were transferred intravenously into naive wild-
type C57BL/6 or Td gene knockout mice. The
recipient mice were ear challenged immediately
thereafter and the CHS response was measured 24
h later. The difference in CHS responses between
wild-type and Td gene knockout recipient mice is
not signi®cant (p > 0.05).
Figure 1. gdT cell de®ciency enhances CHS
responses. Mice were sensitized with 3% OX
and the response was measured following ear
challenge with 1% OX 5 d later. (A) CHS
responses in Td gene knockout and wild-type
mice. The response in Td gene knockout mice is
signi®cantly increased compared to wild-type B6
mice (p < 0.05). (B) The effect of gdT cell
depletion on CHS responses. Wild-type mice
were depleted of gdT cells by in vivo
administration of anti-Td chain antibody prior to
sensitization as described in Materials and Methods.
Mice depleted of gdT cells exhibited signi®cantly
higher CHS responses than nondepleted mice at
all measured time points (p < 0.05±0.01).
Figure 3. The role of CD4+ T cells on regulatory effects of gdT
cells in CHS responses. Wild-type and gdT cell de®cient mice were
depleted of CD4+ T cells prior to sensitization with DNFB by in vivo
administration of anti-CD4 antibody. The control mice were treated
with normal rat IgG. The mice were then sensitized and challenged with
hapten as described. The result is representative of two independent
experiments. The level of CHS responses in gdT cell de®cient mice was
signi®cantly higher than in wild-type mice at all time points (p < 0.05±
0.01).
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mouse strains produced both IFN-g and IL-4 but naive lymph node
cells produced undetectable or background levels of the cytokines.
IL-4 production was similar in both mouse strains whereas the level
of IFN-g in Td gene knockout mice was higher than in wild-type
mice (Fig 4a). Identical cytokine patterns were observed when
hapten-labeled dendritic cells were applied in the stimulation of
hapten-primed T cells in vitro (Fig 4b). The results indicate that the
induction of hapten-primed effector cells that produce IFN-g is
upregulated in Td gene knockout mice.
To selectively determine the effect of gdT cell de®ciency on
cytokine production by hapten-primed abT cell subpopulations,
wild-type and Td gene knockout mice were depleted of CD4+ or
CD8+ T cells prior to sensitization and the draining lymph node
cells were taken in cultures for examination of cytokine produc-
tion. In accordance with our previous studies (Xu et al, 1996),
depletion of CD4+ T cells abrogated IL-4 production whereas
depletion of CD8+ T cells greatly reduced IFN-g production by
hapten-primed T cells (Fig 4c). IL-4 production by primed CD4+
T cells was not remarkably different when Td gene knockout and
wild-type mice were compared. In contrast, the IFN-g level
produced by CD8+ T cells was moderately increased in Td gene
knockout. The pattern was identical to that observed in mice
without T cell depletion.
Collectively, the analysis of cytokine production by primed T
cells indicates that a defect in gdT cells does not affect the
development of CD4+ cells in CHS, but it does increase Th1
cytokine IFN-g production by hapten-primed T cells, especially
CD8+ T cells.
CTL activity of hapten-speci®c T cells A recent study has
demonstrated that the cytolytic activity of hapten-speci®c T cells is
mandatory for the development of CHS responses (Kehren et al,
1999). The effect of gdT cells on CTL activity of hapten-primed T
cells was therefore assessed. In preliminary studies we found that
effector cells with signi®cant CTL activity could be obtained when
draining lymph node cells from hapten-primed mice were
stimulated in vitro on anti-CD3 antibody coated wells in the
presence of IL-2. Kinetic studies revealed that effector cells
harvested 3±4 d after in vitro stimulation exhibited the highest
speci®c CTL activity (data not shown). Under these conditions,
CTL T cells lyzed hapten-labeled EL-4 target cells but not
unlabeled targets. Hapten-primed T cells from both wild-type and
Td gene knockout mice exhibited signi®cant levels of CTL activity
to the hapten-labeled target cells (Fig 5). The hapten-speci®c lysis
of target cells by wild-type primed T cells was about 10% at the E:T
ratio 100:1. This was a reproducible ®nding in four separate
experiments. The primed T cells from Td gene knockout mice
Figure 5. The CTL activity of hapten-
primed T cells from wild-type B6 and Td
gene knockout mice. Mice were sensitized
twice with DNFB and the draining lymph node
and spleen cells were harvested 4 d later. The cells
were stimulated in vitro on anti-CD3 antibody
coated wells in the presence of IL-2 for 4 d.
Naive lymph node T cells stimulated with anti-
CD3 were used as negative control (unprime).
The cytolytic activity was measured by standard
51Cr release CTL assay using DNBS-labeled EL-4
cells as targets (hp-label). Unlabeled EL-4 cells
(unlabel) were used as control for nonspeci®c
lysis. The ®gures show representative results from
four separate experiments.
Figure 4. The cytokine pro®le of hapten-
primed T cells from wild-type B6 and Td
gene knockout mice. Mice were sensitized with
DNFB and the draining lymph node cells were
harvested for stimulation in vitro on anti-CD3
antibody coated wells (A, C) or with DNBS-
labeled dendritic cells (B). Cytokines in the
supernatants were measured by cytokine-speci®c
ELISA. (A) IFN-g and IL-4 production in wild-
type and gdT cell de®cient mice, which was
stimulated by anti-CD3 antibody. (B) Cytokine
production stimulated by DNBS-labeled dendritic
cells. (C) Cytokine production by CD4+ or
CD8+ T cells, which was stimulated by anti-CD3
antibody. The ®gures show representative results
of two to three independent experiments.
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showed a signi®cantly higher level of CTL activity, average 2±3
times, than those cells from primed wild-type mice (Fig 5).
DISCUSSION
gdT cells play different roles in in¯ammatory reactions. In general,
gdT cells function as regulatory cells in immune responses although
they can be effector cells in certain situations (Born et al, 1999;
Hayday, 2000). The purpose of this study was to determine
whether gdT cells play a role in the induction of hapten-speci®c
effector T cells and to de®ne how gdT cells regulate the cell
population during CHS responses. The data clearly indicate that
gdT cells play an inhibitory role in CHS responses and down-
regulate the induction of hapten-speci®c CD8+ effector cells in a
CD4+ T cell independent manner.
Our results indicate that gdT cells are not effector cells in the
development of CHS responses, in accordance with the ®ndings
from other laboratories (Szczepanik et al, 1996). In both Td gene
knockout animals and mice depleted of gdT cells by antibody
treatment CHS responses were increased, indicating that they are
regulatory cells capable of inhibiting CHS responses. The anti-
in¯ammatory effects of gdT cells have also been observed in other
cell-mediated immune responses such as delayed-type hypersensi-
tivity. In Td gene knockout animals, the in¯ammatory reaction to
Mycobacterium infection is enhanced, which results in higher
mortality in infected animals (D'Souza et al, 1997). Similar ®ndings
were reported in a model of murine lupus, in which the
autoimmune response was exaggerated in gdT cell de®cient animals
(Mukasa et al, 1995). In contrast to cell-mediated immune
responses, gdT cells are required for the induction of humoral
immune responses. Depletion of gdT cells either by antibody
treatment or by Td gene targeted disruption inhibits the develop-
ment of allergic airway in¯ammation (Zuany-Amorim et al, 1998)
and oral antigen induced mucosal immune responses (Fujihashi et
al, 1996).
Although gdT cells play an anti-in¯ammatory role in both CHS
and delayed-type hypersensitivity responses, the mechanism by
which they regulate those responses is different. In delayed-type
hypersensitivity responses induced by protein antigens, CD4+ Th1
cells are the effector cells and Th2 cells the regulatory cells. gdT
cells favor the development of Th2 cells and a defect in gdT cells
shifts the phenotype toward increased Th1 activities. This in turn
affects the magnitude of delayed-type hypersensitivity responses
(Huber et al, 1999). In CHS responses, the effect of gdT cells is not
dependent on CD4+ T cells. The pattern of CHS responses in gdT
cell de®cient versus wild-type animals was not remarkably altered in
animals with a de®ciency in CD4+ T cells. This is further supported
by our analysis of cytokines produced by hapten-primed T cells.
The de®ciency in gdT cells neither shifted the cytokine pro®le of
CD4+ T cells nor signi®cantly reduced the level of cytokines
produced. The development of hapten-speci®c CD4+ cells in gdT
cell de®cient mice was not signi®cantly affected. In CHS responses,
although CD8+ effector cells can develop independently of CD4+
T cells (Xu et al, 1997a), a change in CD4+ Th1 effector cells or in
Th2 cell development does affect the magnitude of the response
(DiIulio et al, 1996; Tang et al, 1997; Xu et al, 1997b; Wang et al,
1999). The fact that CHS responses were enhanced in gdT cell
de®cient mice in the absence of CD4+ T cells suggests that gdT
cells in CHS directly regulate the function of CD8+ T cells.
The role of gdT cells in regulating CD8+ CTL development has
been reported in previous studies. In vivo treatment with antipan Td
gene antibody, which led to a disappearance of gdT cells in
lymphoid organs, enhanced the development of CTLs (Kaufmann
et al, 1993). In a tolerance model induced by oral administration of
antigen, gdT cells play a key role in the development of
CD8+ noncytolytic regulatory T cells that mediate the tolerance.
In the absence of gdT cells, CD8+ T cells develop into CTL cells
and tolerance is blocked (Ke et al, 1997). Our study indicates that a
defect in gdT cells enhances the development of hapten-speci®c
CD8+ effector cells with higher levels of IFN-g production and
CTL activity. It may result from increased number or enhanced
function of the effector cells.
It is important to note that the magnitude of the change in IFN-g
production was not as great as the change in CTL activity in gdT
cell de®cient mice. Although a line of evidence indicates that
IFN-g plays an important role in T cell mediated in¯ammatory
reactions (Grabbe and Schwarz, 1998), recent studies have
demonstrated that CTL activity is more important for elicitation
of the response (Kehren et al, 1999). At this point, it is not clear
whether IFN-g producing cells and CTL are the same hapten-
speci®c effector cells or different subsets.
In our hands, gdT cells appeared to have little, if any, in¯uence
on the elicitation phase of the CHS response. Transfer of hapten-
primed abT cells elicited CHS responses in gdT cell de®cient
recipients and this occurred in the absence of gdT cells. Although
the level of CHS was slightly lower in gdT cell de®cient recipients
than in wild-type mice, the difference was not statistically
signi®cant. This result contrasts with previous studies indicating
that the transfer of CHS responses by hapten-primed abT cells was
dependent on gdT cells (Askenase et al, 1995; Yokozeki et al, 2001).
Although this disparity cannot be resolved without further
investigation, there are at least three differences between previous
studies and ours. First, our experiments were conducted with the
haptens DNFB and OX, whereas Yokozeki et al employed
paraphenylenediamine (PPD), which undergoes metabolic conver-
sion via the cytochrome P450-dependent enzyme system. There
are reports to suggest that a metabolite of PPD rather than the
parent compound is the immunogenic moiety responsible for CHS.
Differences in the metabolic fate of these two compounds once
they have been applied to the skin may account for the disparity in
the response. Second, as PPD is a relatively weak antigen, the
protocol for sensitization requires its repeated application. This
contrasts with DNFB and OX, which can be applied once or twice
to the skin and result in contact sensitization. From other systems, it
is known that repeated exposure to a contact allergen results in a
change from a Th1 to a Th2 response. An analogous effect could be
taking place here. Repeated application of PPD could result in a
greater role for gdT cells in the elicitation phase of the CHS
response. Finally, the differences could result from differences used
in the techniques employed for isolating the cells for adoptive
transfer. In our studies, gdT cell knockout mice were employed.
Thus, it was not necessary to deplete gdT cells with antibody or
complement prior to adoptive transfer. Treatment of the cell
populations in vitro could alter, by some as yet unde®ned
mechanism, the activity of the transferred cell populations.
The anti-in¯ammatory activities of gdT cells can be directed at
abT cells as well as at natural killer cells (Ladel et al, 1996) and
macrophages (Egan and Carding, 2000). Our data have demon-
strated that CD8+ T cell activation is affected by gdT cells during
hapten sensitization. The regulatory effects of gdT cells on abT cell
development and function can be mediated by different mechan-
isms (Born et al, 1999; Hayday, 2000). Direct cell±cell contact
between gdT cells and abT cells has been reported to be critical for
the regulatory effect of gdT cells (Szczepanik et al, 1998). Activated
gdT cells express high levels of FasL, which can mediate apoptosis
of activated abT cells that express a high level of Fas molecules
(Vincent et al, 1996). This, however, may not be as important for
CHS as gdT cells had little effect during elicitation of the response.
Based on the fact that gdT cells rapidly respond to antigen
stimulation and produce large amounts of cytokines (Hayday,
2000), we speculate that gdT cells produce regulatory cytokines in
response to hapten sensitization, which affect the activation of
CD8+ T cells. Activated gdT cells can produce Th2 cytokines IL-4
and IL-10 that not only play a role in primary immune responses
but also contribute to the development and function of immune
abT cells (Ferrick et al, 1995; Fujihashi et al, 1999). In CHS
responses, IL-10 is the major regulatory cytokine whereas IL-4
appears to play little role (Ferguson et al, 1994; Berg et al, 1995),
which not only downregulates functions of antigen presenting cells
and T cells but also suppresses in¯ammatory reactions. Our
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ongoing experiments will investigate the role of IL-10 in the
regulation of hapten-primed CD8+ T cell development by gdT
cells.
In summary, this study indicates that a de®ciency in gdT cells
exaggerates CHS responses to hapten sensitization and the effect is
independent of CD4+ T cells. Our data have demonstrated that
gdT cells regulate the induction of hapten-speci®c CD8+ cells and
have little effect on the elicitation of CHS responses. Further
studies are under way to explore mechanisms by which gdT cells
regulate the development of hapten-primed CD8+ T cells in CHS
responses.
The work is supported by NIH grants AR46256-02 (HX), CA70396, CN-
85083±57, and CA79820-02 (CE).
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